Manufacturers traditionally design randomized controlled trials (RCTs) to evaluate either the effectiveness of interventions in real-life routine practice conditions (pragmatic) or the efficacy of an intervention (explanatory). Both are critical to developing the right evidence for your product, but manufacturers are looking for ways to conduct them in parallel to support launch more effectively. By merging these objectives in an innovative study design, you can deliver faster, more cost-efficient evidence.